Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Cash from Financing Activities: 2017-2024

Historic Cash from Financing Activities for Bicycle Therapeutics (BCYC) over the last 8 years, with Dec 2024 value amounting to $519.8 million.

  • Bicycle Therapeutics' Cash from Financing Activities rose 99.91% to -$30,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $87,000, marking a year-over-year decrease of 99.98%. This contributed to the annual value of $519.8 million for FY2024, which is 107.88% up from last year.
  • According to the latest figures from FY2024, Bicycle Therapeutics' Cash from Financing Activities is $519.8 million, which was up 107.88% from $250.0 million recorded in FY2023.
  • Bicycle Therapeutics' Cash from Financing Activities' 5-year high stood at $519.8 million during FY2024, with a 5-year trough of $6.7 million in FY2022.
  • In the last 3 years, Bicycle Therapeutics' Cash from Financing Activities had a median value of $250.0 million in 2023 and averaged $258.8 million.
  • Per our database at Business Quant, Bicycle Therapeutics' Cash from Financing Activities crashed by 97.91% in 2022 and then surged by 3,636.21% in 2023.
  • Over the past 5 years, Bicycle Therapeutics' Cash from Financing Activities (Yearly) stood at $62.8 million in 2020, then spiked by 410.36% to $320.7 million in 2021, then tumbled by 97.91% to $6.7 million in 2022, then surged by 3,636.21% to $250.0 million in 2023, then surged by 107.88% to $519.8 million in 2024.